David P Nicolau

44PUBLICATIONS
41CO-AUTHORS
Medical infection agents (incl. prions)BacteriologyMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Mar 23, 2026
Antimicrobial activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025).

Elizabeth Cyr, Jill Argotsinger, Eric T Beck

|Jul 24, 2025
Sulbactam-durlobactam in combination with aztreonam and carbapenems against carbapenem-resistant Acinetobacter baumannii: an assessment using the MIC-based broth disk elution.

C Koenig, D P Nicolau, T E Asempa

|Jul 17, 2025
Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against Acinetobacter baumannii-calcoaceticus complex strains isolated from respiratory and bloodstream sources: results from ACNBio study.

Ecem Buyukyanbolu, Jill Argotsinger, Eric T Beck

|May 30, 2025
An ex vivo model to determine transmembrane clearance of antimicrobials during continuous renal replacement therapy.

Cole McGrath, Christina Koenig, Hanna F Roenfanz

|Apr 15, 2025
Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns.

Jay D Olivet, Megan Amerson-Brown, Juan J Calix

|Apr 03, 2025
Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of Enterobacterales from outpatient centers and nursing homes across the United States (2022-2024).

Aliaa Fouad, April M Bobenchik, Robin Chamberland

Pageof 8

Frequent Collaborators

12 joint publications

Tomefa E Asempa

12 joint publications

Joseph L Kuti

4 joint publications

Kamilia Abdelraouf

3 joint publications

Holly K Huse